<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 31-year-old man with refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> of excess blasts, which had karyotypic abnormalities, received an allogeneic bone marrow transplant (BMT) </plain></SENT>
<SENT sid="1" pm="."><plain>At time of relapse, 3 months after BMT, he was treated with donor leucocyte transfusion (DLT) </plain></SENT>
<SENT sid="2" pm="."><plain>Grade III <z:hpo ids='HP_0011009'>acute</z:hpo> GVHD (<z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e>) occurred 35 d after DLT which was fully reversed with cyclosporin and <z:chebi fb="2" ids="8378">prednisolone</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>His condition was complicated by a <z:e sem="disease" ids="C0019360" disease_type="Disease or Syndrome" abbrv="ZONA">herpes zoster infection</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>2 months after DLT, neutrophil and platelet count were increased and karyotypic abnormalities disappeared </plain></SENT>
<SENT sid="5" pm="."><plain>This observation demonstrates that DLT is an effective treatment for relapse of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) after BMT </plain></SENT>
</text></document>